Literature DB >> 18656353

Factors that influence health-related quality of life in Australian adults with Charcot-Marie-Tooth disease.

Anthony C Redmond1, Joshua Burns, Robert A Ouvrier.   

Abstract

Health-related, quality of life (HRQoL) is an important outcome in clinical trials of patients with Charcot-Marie-Tooth disease (CMT). In a cross-sectional survey of 295 Australian adults with CMT, HRQoL was measured using the Short Form-36 (SF-36) and predictors of reduced HRQoL were identified with a CMT-specific health status questionnaire. People with CMT demonstrated lower HRQoL scores than the general Australian population in all SF-36 dimensions. The disparity between people with CMT and normative data was greater for physical dimensions than for mental health dimensions. SF-36 scores were generally lower in older vs younger people, but not between men and women, or between CMT types. HRQoL in CMT was predicted strongly by lower limb weakness and to a lesser extent by leg cramps, suggesting clinical trials targeting weakness and cramps may improve HRQoL in patients with CMT.

Entities:  

Mesh:

Year:  2008        PMID: 18656353     DOI: 10.1016/j.nmd.2008.05.015

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  17 in total

Review 1.  Quality of life in rare genetic conditions: a systematic review of the literature.

Authors:  Julie S Cohen; Barbara B Biesecker
Journal:  Am J Med Genet A       Date:  2010-05       Impact factor: 2.802

2.  Quality of life predictors in patients with chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Ivo Bozovic; Aleksandra Kacar; Stojan Peric; Ana Nikolic; Bogdan Bjelica; Mina Cobeljic; Milutin Petrovic; Aleksandar Stojanov; Vanja Djuric; Miroslav Stojanovic; Gordana Djordjevic; Vesna Martic; Aleksandra Dominovic; Zoran Vukojevic; Ivana Basta
Journal:  J Neurol       Date:  2017-10-30       Impact factor: 4.849

3.  Muscle cramp in pediatric Charcot-Marie-Tooth disease type 1A: prevalence and predictors.

Authors:  Fiona Blyton; Monique M Ryan; Robert A Ouvrier; Joshua Burns
Journal:  Neurology       Date:  2011-11-30       Impact factor: 9.910

4.  Prospective study of muscle cramps in Charcot-Marie-tooth disease.

Authors:  Nicholas E Johnson; Janet Sowden; Nuran Dilek; Katy Eichinger; Joshua Burns; Michael P Mcdermott; Michael E Shy; David N Herrmann
Journal:  Muscle Nerve       Date:  2015-02-11       Impact factor: 3.217

5.  Impact of nocturnal calf cramping on quality of sleep and health-related quality of life.

Authors:  Fiona Hawke; Vivienne Chuter; Joshua Burns
Journal:  Qual Life Res       Date:  2012-09-26       Impact factor: 4.147

Review 6.  Non-drug therapies for lower limb muscle cramps.

Authors:  Fiona Blyton; Vivienne Chuter; Kate E L Walter; Joshua Burns
Journal:  Cochrane Database Syst Rev       Date:  2012-01-18

Review 7.  Neurogenic muscle cramps.

Authors:  Hans D Katzberg
Journal:  J Neurol       Date:  2015-02-12       Impact factor: 4.849

8.  Quality-of-life in Charcot-Marie-Tooth disease: the patient's perspective.

Authors:  Nicholas E Johnson; Chad R Heatwole; Nuran Dilek; Janet Sowden; Callyn A Kirk; Denise Shereff; Michael E Shy; David N Herrmann
Journal:  Neuromuscul Disord       Date:  2014-06-27       Impact factor: 4.296

9.  The Charcot-Marie-Tooth Health Index: Evaluation of a Patient-Reported Outcome.

Authors:  Nicholas E Johnson; Chad Heatwole; Peter Creigh; Michael P McDermott; Nuran Dilek; Man Hung; Jerry Bounsanga; Wan Tang; Michael E Shy; David N Herrmann
Journal:  Ann Neurol       Date:  2018-08-29       Impact factor: 10.422

10.  Non-drug therapies for the secondary prevention of lower limb muscle cramps.

Authors:  Fiona Hawke; Sean G Sadler; Hans Dieter Katzberg; Fereshteh Pourkazemi; Vivienne Chuter; Joshua Burns
Journal:  Cochrane Database Syst Rev       Date:  2021-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.